Abstract
Interleukin-2 (IL-2) is a lymphokine synthesized by some T-cells following activation. Resting T-cells do not express IL-2 receptors but receptors are rapidly expressed on T-cells following the interaction of antigens, mitogens, or monoclonal antibodies with the antigen specific T-cell receptor complex. Using anti-Tac a monoclonal antibody that recognizes the IL-2 receptor, the receptor has been purified. The receptor is a 33kd peptide that is posttranslationally glycosylated to a 55kd mature form. Mature receptors contain both N-linked and O-linked sugars and are both sulfated and phosphorylated. Using an oligonucleotide probe, based on the N-terminal amino acid sequence, cDNAs encoding this receptor have been cloned, sequenced and expressed. The addition of anti-Tac to in vitro culture systems blocks the IL-2 induced DNA synthesis of IL-2 dependent T-cell lines and inhibits soluble auto- and alloantigen induced T-cell proliferation. Furthermore, it prevents the generation of cytotoxic and suppressor effector T cells. The anti-receptor antibody also inhibits lectin stimulated immunoglobulin synthesis and the sequential expression of late appearing activation antigens on T-cells. Normal resting T-cells and most leukemic T-cell populations do not express IL2 receptors however the leukemic cells of all patients with human T-cell leukemia/lymphoma virus (HTLV-1) associated, adult T-cell leukemia (ATL) examined expressed the Tac antigen. In HTLV-I infected cells the 42kd LOR protein encoded in part, by the pX region of HTLV-I may act as a transacting transcriptional activator that induces transcription of the IL-2 receptor gene thus providing an explanation for the constant association of HTLV-I infection of lymphoid cells and IL-2 receptor expression. The constant display of large numbers of IL-2 receptors which may be aberrant in the ATL cells may play a role in the uncontrolled growth of these leukemic T-cells. Patients with the Tac positive adult T-cell leukemia are being treated with the anti-Tac monoclonal antibody directed towards this growth factor receptor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allison, J.P., Mclntyre, B.W. and Bloch, D. J. Immunol. 129:2293, 1982.
Haskins, K., Kubo, R., White, J., Pigeon, M., Kappler, J., Marrack, P. J. Exp. Med. 157:1149, 1983.
Meuer, S.C., Fitzgerald, K.A., Hussey, R.E., Hodgdon, J.C., Schlossman, S.F. and Reinherz, E.L. J. Exp. Med. 157:705, 1983.
Morgan, D.A., Roscetti, F.W., and Gallo, R.C. Science (Wash. DC) 193:1007, 1983.
Smith, K.A. Immunol. Rev. 51:337, 1980.
Robb, R.J., Munck, A., Smith, K.A. J. Exp. Med. 154:1455, 1981.
Uchiyama, T., Broder, S., and Waldmann, T.A. J. Immunol. 126:1393, 1981.
Leonard, W.J., Depper, J.M., Uchiyama, T., Smith, K.A., Waldmann, T.A. and Greene, W.C. Nature (Lond.). 300:267, 1982.
Leonard, W.J., Depper, J.M., Robb, R.J., Waldmann, T.A., and Greene, W.C. Proc. Natl. Acad. Sci. USA 80:6957, 1983.
Robb, R.J., and Greene, W.C. J. Exp. Med. 158:1332, 1983.
Leonard, W.J., Deper, J.M., Waldmann, T.A. and Greene, W.C. (Receptors and Recognition. Series B. Volume 17) (M.F. Greaves ed. pp. 45–46. Chapman and Hall publishers London.
Leonard, W.J., Depper, J.M., Crabtree, G.R., Rudikoff, S., Pumphrey, J., Robb, R.J., Kronke, M., Svetlik, P.B., Peffer, N.J., Waldmann, T.A., and Greene, W.C. Nature. 311:626, 1984.
Uchiyama, T., Nelson, D.L., Fleisher, T.A., and Waldmann, T.A. J. Immunol. 126:1398, 1981.
Depper, J.M., Leonard, W.J., Waldmann, T.A., and Greene, W.C. J. Immunol. 131:690, 1983.
Waldmann, T.A., Goldman, C.K., Robb, R.J., Depper, J.M., Leonard, W.J., Sharrow, S.O., Bongiovanni, K.F., Korsmeyer, S.J. and Greene, W.C. J. Exp. Med. 160:1450, 1984.
Neckers, L.M., and Cossman, J. Proc. Natl. Acad. Sci. USA 80:3494, 1983.
Tsudo, M., Uchiyama, T., Takatsuki, K., Uchino, H., and Yodoi, J. J. Immunol. 129:592, 1982.
Howard, M. and Paul, W.E. Ann. Rev. Immunol. 1:307, 1983.
Korsmeyer, S.J., Greene, W.C., Cossman, J., Hsu, S.M., Jensen, J.P., Neckers, LM., Marshall, S.L., Bakhshi, A., Leonard, W.J., Jaffe, E.S., and Waldmann, T.A. Proc. Natl. Acad. Sci. USA. 80:4522, 1983.
Waldmann, T.A., Greene, W.C., Sarin, P.S., Saxinger, C. Blayney, W., Blattner, W.A., Goldman, C.K., Bongiovanni, K., Sharrow, S., Depper, J.M., Leonard, W., Uchiyama, T., and Gallo, R.C. J. Clin. Invest. 73:1711, 1984.
Poiesz, B.J., Ruscetti, F.W., Gazdar, A.F., Bunn, P.A., Minna, J.D., and Gallo, R.C. Proc. Natl. Acad. Sci. USA. 77:7415, 1980.
Gallo, R.C., and Wong-Staal, F. Blood. 60:545, 1982.
Depper, J.M., Leonard, W.J., Kronke, M., Waldmann, T.A. and Greene, W.C. J. Immunol. 133:1691, 1984.
Leonard, W.J., Depper, J.M., Roth, J.S., Rudikoff, S., Waldmann, T.A. and Greene, W.C. Clin. Res. 31:348A, 1983.
Uchiyama, T., Wano, Y., Tsudo, M., Umadome, H., Hori, T., Tamori, S., Yodoi, J. and Maeda, M. Miwa, M. (ed.) Japan Sci. Soc. Press, in press.
Haseltine, W.A., Sodroski, J.G., Patarca, R., Briggs, D., Perkins, D. and Wong-Staal, F. Science. 225: 419, 1984.
Seiki, M., Hattori, S., Hirayama, Y., and Yoshida, M. Proc. Natl. Acad. Sci. USA. 80:3618, 1983.
Hedrick, S.M., Cohen, D.I., Nielsen, E.A., and Davis, M.M. Nature 308:149, 1984.
Kronke, M., Depper, J.M., Leonard, W.J., Vitetta, E.S., Waldmann, T.A. and Greene, W.C. Blood, in press.
Fitzgerald, D.J.P., Waldmann, T.A., Willingham, M.C., and Pastan, I. J. Clin. Invest. 74: 966, 1984.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 The Humana Press Inc.
About this chapter
Cite this chapter
Waldmann, T.A. et al. (1985). Interleukin-2 Receptors. In: Feldmann, M., Lamb, J.R., Woody, J.N. (eds) Human T Cell Clones. Experimental Biology and Medicine, vol 9. Humana Press. https://doi.org/10.1007/978-1-4612-4998-6_26
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4998-6_26
Publisher Name: Humana Press
Print ISBN: 978-1-4612-9391-0
Online ISBN: 978-1-4612-4998-6
eBook Packages: Springer Book Archive